Al's Comment:

 This is a CAR-T cell trial. It is accepting children with any type of recurrent brain tumor that expresses the HER-2 receptor.

 

---

Posted on: 06/22/2018

Seattle Children’s aims to cure terminal brain cancer using immunotherapy with new BrainChild initiative

https://www.geekwire.com/2018/seattle-childrens-launches-brainchild-new-push-cure-children-terminal-brain-cancer-using-immunotherapy/

 

---

Click HERE to return to brain tumor news headlines.